Clinical and pharmacological group: & nbsp

Spasmolytics myotropic

Included in the formulation
АТХ:

A.03.A.X   Other drugs used in bowel disorders

Pharmacodynamics:

The drug is an essential oil obtained from the leaves and stems of mint. The composition of the drug includes such active substances as menthol esters, cineole, pinenes, menthol, dipentene, menton, jasmone, fellandren, pulegon, esters of acetic and valeric acids.

The drug is irritating predominantly "cold" receptors of the oral cavity and nasopharynx, reduces reflex excitability in the central parts of the nervous system, increases inhibition in the neurons of the cortex and subcortical structures of the brain, reduces the activity of the central vasomotor centers. The drug has a local anesthetic effect, contributes to the reflex expansion of the vessels of the brain, heart and lungs; reduces vomiting, nausea and hiccups, removes skin itching, improves intestinal motility, saliva, helps reduce pressure in the large intestine, eliminates flatulence and has a karminative effect.

Essential oils that make up the drug have an antispasmodic effect on the urinary tract and smooth muscles of the gastrointestinal tract, stimulate the secretory activity of the digestive glands, exert mucolytic, expectorant,choleretic and moderate antihypoxic effect with inhalation.

The drug also has a deodorizing, antiseptic and refreshing effect.

Pharmacokinetics:

Not described.

Indications:

The drug is used as part of complex therapy to achieve analgesic, karminativnogo, cholagogue, deodorizing and disinfecting effect. As a symptomatic for nausea and vomiting, spastic pain of the gastrointestinal tract.

XVIII.R00-R09.R07   Sore throat and chest

XVIII.R10-R19.R10.4   Other and unspecified abdominal pain

XVIII.R10-R19.R14   Meteorism and related conditions

XVIII.R50-R69.R51   Headache

Contraindications:

Hypersensitivity, age to 18 years, inflammatory diseases of the oral mucosa, a deficiency of sugar / isomaltase, fructose intolerance, glucose-galactose malabsorption.

Carefully:

Gallstone disease (with ingestion), diabetes mellitus.

Pregnancy and lactation:

Category FDA not determined. Use of the drug is possible after consultation with a doctor.

Dosing and Administration:

The dose is selected by the attending physician individually, depending on the indications,the dosage form of the preparation and the clinical parameters of the patient.

Inside (tablets are kept in the mouth until complete resorption), 1-2 tablets up to 6 times a day. The maximum daily dose is 8 tablets.

Side effects:

Allergic reactions, irritation of the oral mucosa.

Overdose:

Not described.

Interaction:

Weakens the effect of homeopathic medicines.

Special instructions:

Impact on the ability to drive vehicles and manage mechanisms

Does not affect the performance of potentially hazardous activities requiring special attention and quick reactions (vehicle management, dispatcher, operator).

Instructions
Up